Equillium, Inc. (EQ)
2.20
-0.11
(-4.76%)
USD |
NASDAQ |
Aug 24, 16:00
2.24
+0.04
(+1.82%)
After-Hours: 20:00
Equillium Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | 99.20% |
| September 30, 2024 | 99.71% |
| June 30, 2024 | 99.75% |
| March 31, 2024 | 99.70% |
| December 31, 2023 | 99.64% |
| Date | Value |
|---|---|
| September 30, 2023 | 99.65% |
| June 30, 2023 | 99.66% |
| March 31, 2023 | 99.65% |
| December 31, 2022 | 99.80% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 99.60% |
| Fortress Biotech, Inc. | 61.50% |
| Cue Biopharma, Inc. | 99.54% |
| Legend Biotech Corp. | 61.52% |
| Dianthus Therapeutics, Inc. | 85.94% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -50.00% |
| Return on Assets | -44.86% |
| Return on Invested Capital | -49.18% |
| Return on Net Operating Assets | -1.92K% |